Dr. Wang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2100 Erwin Rd
Durham, NC 27705Phone+1 919-684-8111Fax+1 919-681-7177
Education & Training
Brigham and Women's HospitalResidency, Internal Medicine, 2001 - 2004
Harvard Medical SchoolClass of 2001
Certifications & Licensure
CA State Medical License 2024 - 2026
NC State Medical License 2004 - 2025
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- PLATFORM to Maximize Patient Knowledge of Health Goals After Acute Myocardial Infarction Start of enrollment: 2013 Mar 01
Publications & Presentations
PubMed
- Which outcomes are most important to measure in patients with COVID-19 and how and when should these be measured? Development of an international standard set of outco...William Seligman, Luz Sousa Fialho, Nick Sillett, Christina Nielsen, Farhala M Baloch
BMJ Open. 2021-11-15 - 31 citationsHarnessing Mobile Health Technology for Secondary Cardiovascular Disease Prevention in Older Adults: A Scientific Statement From the American Heart AssociationErica N. Schorr, Adam D. Gepner, Mary A. Dolansky, Daniel E. Forman, Linda G Park
Circulation. Cardiovascular Quality and Outcomes. 2021-04-01 - 94 citationsSex-Based Differences in Outcomes After Percutaneous Coronary Intervention for Acute Myocardial Infarction: A Report From TRANSLATE-ACSConnie N. Hess, Lisa A. McCoy, Hesha Duggirala, Dale R. Tavris, Kathryn M. O’Callaghan
Journal of the American Heart Association. 2014-01-03
Journal Articles
- Time to End “Manels” in Clinical Trial LeadershipTracy Y Wang, Jacqueline Talea Desjardin, JAMA Internal Medicine
- Time to End “Manels” in Clinical Trial LeadershipTracy Y Wang, Jacqueline Talea Desjardin, JAMA Internal Medicine
- Implications of ST Changes During Normal Echocardiography—ReplyMelissa A Daubert, Tracy Y Wang, JAMA Internal Medicine
- Join now to see all
Authored Content
- Time to End “Manels” in Clinical Trial LeadershipAugust 2020
- Implications of ST Changes During Normal Echocardiography—ReplyJune 2020
- Performance of Hospitals When Assessing Disease-Based Mortality Compared with Procedural Mortality for Patients with Acute Myocardial InfarctionMay 2020
- New ACC/AHA Quality Measures for Cardiac RehabilitationApril 2018
- New ACC/AHA Quality Measures for Cardiac RehabilitationApril 2018
- 2018 ACC/AHA Clinical Performance and Quality Measures for Cardiac Rehabilitation A Report of the American College of Cardiology/American Heart Association Task Force on Performance MeasuresApril 2018
- Join now to see all
Press Mentions
Heart Risk Factors, Not Heart Disease Itself, May Increase Odds of COVID-19 DeathOctober 4th, 2022- AHA: Novel Oral Factor XIa Inhibitor Prevents VTE in Knee ArthroplastyNovember 17th, 2021
- AHA: Novel Oral Factor XIa Inhibitor Demonstrates Prevents VTE in Knee ArthroplastyNovember 16th, 2021
- Join now to see all
Professional Memberships
- Member
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
